The Drug Science Podcast

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.
Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.

Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don't miss out - listen to our latest episode now!

Listen to Graham's music here!

 Psychedelic Assisted Therapy
 Small Pharma
 Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant
 Bipolar disorder
 Schizoaffective disorder
 Trial of Psilocybin versus Escitalopram for Depression
 Rosalind Watts
 Michelle Baker Jones
 Roberta Murphy 
 Jonny Martell
 Ashleigh Murphy-Beiner
 Institute of Psychedelic Therapy
 The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
 Sussex Partnership NHS Foundation Trust
 Monoamine oxidase inhibitor
 The ACE Model
 The hidden therapist: evidence for a central role of music in psychedelic therapy
 Max Cooper
 Music and the Mind by Anthony Storr
 Mind Foundation
 Maria Papaspyrou
★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.